Delivery Order SPE2DB20D7059-SPE2DB24FQNT8

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.75 firm fixed-price delivery order contract is for the supply of Cetirizine HCL 10 mg tablets. The contract is not designated as a set-aside and serves as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,780.54 firm fixed-price delivery order is for the supply of 4,566,372,069 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of November 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,514.12 firm fixed-price delivery order is for the supply of cetirizine hydrochloride 10 mg tablets, a common antihistamine medication, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $7,709.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,601,125 units of Cetirizine Hydrochloride 10 mg tablets, a generic pharmaceutical product used to treat allergies. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 26, 2023. It is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,294,529 Cetirizine Hydrochloride 5 mg tablets in 100 count bottles. The $3,708.42 firm fixed-price delivery order has a completion date of July 31, 2024 and is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, has been awarded multiple indefinite delivery contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,696.62 Firm Fixed Price Delivery Order contract is for the supply of Cetirizine HCL 10 mg Tablets. No set-aside designation was used. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,880 units of Cetirizine HCL 10 mg tablets. The $8,582.74 firm fixed price contract has a completion date of February 9, 2023 and was awarded on February 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,686.91 firm fixed-price delivery order covers the supply of 4,566,693,120 units of the drug Cetirizine HCL 10 mg tablets. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,255.72 firm fixed-price delivery order is for the supply of 4,567,497,393 units of cetirizine HCl 10 mg tablets in 500-count bottles. The contract has an ultimate completion date of March 10, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQNT8
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cetirizine Hydrochloride 10 mg Tablets, packaged in 300-count bottles. The $2,490.44 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract award has no set-aside designation and is scheduled for completion by September 27, 2024.

Generated 12/26/24, 9:25 AM